drugset / Trial / NCT00179283
Sertraline vs. Venlafaxine XR
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, active control, 8-week, flexible dose study of sertraline vs. venlafaxine Extended Release in the acute treatment of Major Depression in male and female outpatient sites that will recruit 15-20 patients each. Subjects will be randomized in a 1:1 ratio to receive either sertraline or venlafaxine XR based on a computer-generated randomized list.
Timeline
- Start
- 2002-04
- Primary completion
- —
- Completion
- 2003-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sertraline | Small molecule | 150 mg | — |
| Subject | Venlafaxine | Small molecule | 225 mg | — |